Findings
Discoveries at the intersection of cognition, design, and therapeutic innovation
Unreleased
Indalarium
Pharmacology Patent
Patent claims for novel compounds targeting therapeutic use in Parkinson's disease
Stage: Legal Process
In Progress
Xanthimine
Pharmacology
Discovery of a novel stimulant class with a new set of profiles and pharmacokinetic mechanisms.
Stage: Architectural Understanding
In Progress
DesoxyThea
Pharmacology
Patent claims for prodrug targeting therapeutic use in attention-deficit/hyperactivity disorders.
Stage: Synthesis path discovery
Under Evaluation
Indagiline
Pharmacology Patent
Patent claims for novel compounds targeting therapeutic use in Parkinson's disease
Impact: Currently Theoretical